We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
Cap. Flow
-$4.15B
Cap. Flow %
-9.34%
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$309M
2
XOM icon
ExxonMobil
XOM
+$302M
3
AMZN icon
Amazon
AMZN
+$291M
4
C icon
Citigroup
C
+$253M
5
SHOP icon
Shopify
SHOP
+$238M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$383M
2
JNJ icon
Johnson & Johnson
JNJ
+$312M
3
JPM icon
JPMorgan Chase
JPM
+$285M
4
T icon
AT&T
T
+$191M
5
DG icon
Dollar General
DG
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 15.63%
2 Financials 15.61%
3 Technology 14.28%
4 Consumer Discretionary 13.21%
5 Industrials 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AISPW
1026
CALL
Airship AI Holdings Warrants
AISPW
$15.6M
$6.3M 0.01%
624,997
PG icon
1027
CALL
Procter & Gamble
PG
$347B
$6.29M 0.01%
41,500
-5,200
-11% -$729K
SAFE
1028
Safehold
SAFE
$1.2B
$6.28M 0.01%
131,676
+16,572
+14% +$798K
SUAC.WS
1029
CALL
DELISTED
ShoulderUp Technology Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
SUAC.WS
$6.26M 0.01%
609,902
SOAR icon
1030
Volato Group
SOAR
$7.18M
$6.25M 0.01%
24,595
TWOA
1031
DELISTED
two
TWOA
$6.25M 0.01%
620,975
FRC
1032
DELISTED
First Republic Bank
FRC
$6.25M 0.01%
+51,300
New +$6.26M
FOX icon
1033
Fox Class B
FOX
$21.4B
$6.24M 0.01%
219,273
-320,793
-59% -$9.18M
PDD icon
1034
CALL
Pinduoduo
PDD
$120B
$6.21M 0.01%
76,100
+6,100
+9% +$425K
LGND icon
1035
Ligand Pharmaceuticals
LGND
$5.97B
$6.2M 0.01%
92,863
+28,931
+45% +$1.88M
EWZ icon
1036
PUT
iShares MSCI Brazil ETF
EWZ
$9.07B
$6.2M 0.01%
221,600
+87,300
+65% +$2.67M
COCHW icon
1037
CALL
Envoy Medical Warrant
COCHW
$564K
$6.2M 0.01%
613,624
RYZ
1038
Ryerson Holding Corp
RYZ
$1.58B
$6.19M 0.01%
204,608
-127,978
-38% -$3.8M
PYPL icon
1039
PUT
PayPal
PYPL
$49.6B
$6.17M 0.01%
86,700
+36,700
+73% +$2.94M
SLCA
1040
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$6.17M 0.01%
493,697
+331,499
+204% +$4.24M
TX icon
1041
Ternium
TX
$9.28B
$6.17M 0.01%
201,839
+179,084
+787% +$5.35M
JKS
1042
JinkoSolar
JKS
$799M
$6.14M 0.01%
150,304
-147,769
-50% -$7.12M
LRCX icon
1043
Lam Research
LRCX
$364B
$6.14M 0.01%
146,040
-5,460
-4% -$228K
ADAL
1044
DELISTED
Anthemis Digital Acquisitions I Corp Class A Ordinary Shares
ADAL
$6.1M 0.01%
593,458
BLMN icon
1045
Bloomin' Brands
BLMN
$734M
$6.1M 0.01%
+303,152
New +$6.57M
WPCA
1046
DELISTED
Warburg Pincus Capital Corporation I-A
WPCA
$6.1M 0.01%
603,620
FRBN
1047
DELISTED
Forbion European Acquisition Corp. Class A Ordinary Shares
FRBN
$6.09M 0.01%
588,609
LHC
1048
DELISTED
Leo Holdings Corp. II
LHC
$6.08M 0.01%
602,940
-1,210,921
-67% -$12.1M
BACA.WS
1049
CALL
DELISTED
Berenson Acquisition Corp. I Warrants, each whole warrant exercisable for one share of class A common stock at an exercise price of $11.50
BACA.WS
$6.08M 0.01%
601,498
RFP
1050
DELISTED
Resolute Forest Products Inc.
RFP
$6.08M 0.01%
281,576
+181,676
+182% +$3.8M

Similar funds

Marshall Wace's Q4 2022 Portfolio in Review

As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.

  • Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
  • Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
  • Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
  • Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
  • Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
  • Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.